Evidence map›Paper›PMID 31434873›Full record

ArticleBlood cancer journal2019

Exploring tumor clonal evolution in bone marrow of patients with diffuse large B-cell lymphoma by deep IGH sequencing and its potential relevance in relapse.

Jiao Ma, David Redmond, Ayako Miyaguchi, Anna S Nam, Kui Nie, Susan Mathew, Olivier Elemento, Wayne Tam

Open access · goldAbstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Blood cancer journal, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Tumor-targeted IL2 promotes specific CD8Journal of experimental & clinical cancer research : CR · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Jiao MaDepartment of Biochemistry & Molecular Cell Biology, Shanghai Jiaotong University, School of Medicine, Shanghai, China.
David RedmondDepartment of Physiology and Biophysics & Institute for Computational Biomedicine, Weill Cornell Medicine, New York, NY, USA.
Ayako MiyaguchiDepartment of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA.
Anna S NamDepartment of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA.
Kui NieDepartment of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA.
Susan MathewDepartment of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA.
Olivier ElementoDepartment of Physiology and Biophysics & Institute for Computational Biomedicine, Weill Cornell Medicine, New York, NY, USA.
Wayne TamDepartment of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA. wtam@med.cornell.edu.
Cornell University · USWeill Cornell Medicine · US

Funding

The identification and validation of mechanisms and biomarkers for relapse in diffuse large B-cell lymphoma (Administrative Supplement)R01CA194547 · NCI · WEILL MEDICAL COLL OF CORNELL UNIV · PI ELEMENTO, OLIVIER, TAM, WAYNE · 2015 to 2019
$2.6M
NCI NIH HHS R01 CA194547
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Bone MarrowClonal EvolutionFemaleHigh-Throughput Nucleotide SequencingHumansLymphoma, Large B-Cell, DiffuseMaleRecurrence

Identifiers

PMID31434873
PMCPMC6704167
OpenAlexW2969881363

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.